Abiopharma

Director DeSilva Nishan M 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000039

Director Brunn Carsten 🟢 acquired 558.9K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 000038

Director Malik Kemal 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000037

Miljkovic Milos 🟢 acquired 104.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000036

Director ZENNER PATRICK J 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000035

Bishop Hans Edgar 🟢 acquired 6.2K shares of Sana Biotechnology, Inc. (SANA) Transaction Date: Jan 05, 2026 | Filing ID: 000002

Seymour June Ann 🟢 acquired 25.5K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000034

Davis Blaine 🟢 acquired 146.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000033

Coyne Terrance P. 🔴 sold 69.6K shares of Royalty Pharma plc (RPRX) at $38.42 ($2.7M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Wyrick Susan D. 🟡 adjusted position in 2.4K shares (1 derivative) of Sana Biotechnology, Inc. (SANA) at $4.27 Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001317 Size: 30 KB

Director BARABE TIMOTHY C 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000032

English Emily 🟢 acquired 95.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000031

Director Thompson Craig B. 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000001

Director Singer Michael 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000030